Warning: The NCBI web site requires JavaScript to function. more...
Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study.
Morelli A, Ertmer C, Rehberg S, Lange M, Orecchioni A, Cecchini V, Bachetoni A, D'Alessandro M, Van Aken H, Pietropaoli P, Westphal M.
Crit Care. 2009;13(4):R130. Epub 2009 Aug 10.
Related citations
Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: the DOBUPRESS study.
Morelli A, Ertmer C, Lange M, Dünser M, Rehberg S, Van Aken H, Pietropaoli P, Westphal M.
Br J Anaesth. 2008 Apr;100(4):494-503. Epub 2008 Feb 27.
Phenylephrine versus norepinephrine for initial hemodynamic support of patients with septic shock: a randomized, controlled trial.
Morelli A, Ertmer C, Rehberg S, Lange M, Orecchioni A, Laderchi A, Bachetoni A, D'Alessandro M, Van Aken H, Pietropaoli P, Westphal M.
Crit Care. 2008;12(6):R143. Epub 2008 Nov 18.
Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study.
Albanèse J, Leone M, Delmas A, Martin C.
Crit Care Med. 2005 Sep;33(9):1897-902.
Terlipressin in catecholamine-resistant septic shock patients.
Leone M, Albanèse J, Delmas A, Chaabane W, Garnier F, Martin C.
Shock. 2004 Oct;22(4):314-9.
Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinetic septic shock.
Morelli A, Rocco M, Conti G, Orecchioni A, De Gaetano A, Cortese G, Coluzzi F, Vernaglione E, Pelaia P, Pietropaoli P.
Intensive Care Med. 2004 Apr;30(4):597-604. Epub 2003 Dec 12.
Beneficial effects of short-term vasopressin infusion during severe septic shock.
Patel BM, Chittock DR, Russell JA, Walley KR.
Anesthesiology. 2002 Mar;96(3):576-82.
Vasopressin versus norepinephrine infusion in patients with septic shock.
Russell JA, Walley KR, Singer J, Gordon AC, Hébert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ, Ayers D; VASST Investigators.
N Engl J Med. 2008 Feb 28;358(9):877-87.
Role of arginine vasopressin and terlipressin as first-line vasopressor agents in fulminant ovine septic shock.
Rehberg S, Ertmer C, Köhler G, Spiegel HU, Morelli A, Lange M, Moll K, Schlack K, Van Aken H, Su F, Vincent JL, Westphal M.
Intensive Care Med. 2009 Jul;35(7):1286-96. Epub 2009 Apr 10.
Short-term effects of terlipressin bolus infusion on sublingual microcirculatory blood flow during septic shock.
Morelli A, Donati A, Ertmer C, Rehberg S, Orecchioni A, Di Russo A, Pelaia P, Pietropaoli P, Westphal M.
Intensive Care Med. 2011 Jun;37(6):963-9. Epub 2011 Feb 19.
Clinical review: Vasopressin and terlipressin in septic shock patients.
Delmas A, Leone M, Rousseau S, Albanèse J, Martin C.
Crit Care. 2005 Apr;9(2):212-22. Epub 2004 Sep 9. Review.
Effects of continuous vasopressin infusion in patients with septic shock.
Obritsch MD, Jung R, Fish DN, MacLaren R.
Ann Pharmacother. 2004 Jul-Aug;38(7-8):1117-22. Epub 2004 Jun 3.
"Terlipressin in the treatment of septic shock: the earlier the better"?
Morelli A, Ertmer C, Westphal M.
Best Pract Res Clin Anaesthesiol. 2008 Jun;22(2):317-21. Review.
Vasopressin vs. terlipressin in the treatment of cardiovascular failure in sepsis.
Lange M, Ertmer C, Westphal M.
Intensive Care Med. 2008 May;34(5):821-32. Epub 2007 Dec 8. Review.
The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis.
Dünser MW, Mayr AJ, Ulmer H, Ritsch N, Knotzer H, Pajk W, Luckner G, Mutz NJ, Hasibeder WR.
Anesth Analg. 2001 Jul;93(1):7-13.
Terlipressin dose response in healthy and endotoxemic sheep: impact on cardiopulmonary performance and global oxygen transport.
Westphal M, Stubbe H, Sielenkämper AW, Borgulya R, Van Aken H, Ball C, Bone HG.
Intensive Care Med. 2003 Feb;29(2):301-8. Epub 2002 Nov 30.
Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock.
Russell JA, Walley KR, Gordon AC, Cooper DJ, Hébert PC, Singer J, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ; Dieter Ayers for the Vasopressin and Septic Shock Trial Investigators.
Crit Care Med. 2009 Mar;37(3):811-8.
An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response.
Sharma P, Kumar A, Shrama BC, Sarin SK.
Am J Gastroenterol. 2008 Jul;103(7):1689-97. Epub 2008 Jun 28.
Glibenclamide dose response in patients with septic shock: effects on norepinephrine requirements, cardiopulmonary performance, and global oxygen transport.
Morelli A, Lange M, Ertmer C, Broeking K, Van Aken H, Orecchioni A, Rocco M, Bachetoni A, Traber DL, Landoni G, Pietropaoli P, Westphal M.
Shock. 2007 Nov;28(5):530-5.
Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial.
Lauzier F, Lévy B, Lamarre P, Lesur O.
Intensive Care Med. 2006 Nov;32(11):1782-9. Epub 2006 Sep 22.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on